Information  X 
Enter a valid email address

MILLENNIUM PARTNERS, L.P. (0Y7T)

  Print      Mail a friend       Annual reports

Friday 07 February, 2020

MILLENNIUM PARTNERS, L.P.

Form 8.3 - Allergan plc

Form 8.3 - Allergan plc

Millennium Partners, L.P.

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

6 February 2020

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,575,196

(1.089%)

1,890

(0.001%)

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3,575,196

(1.089%)

1,890

(0.001%)

 

b. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

a. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

(USD)

Sale

7,463

192.88

Sale

2,229

192.88

Purchase

200

192.43

Purchase

100

192.33

Purchase

100

192.39

Purchase

100

192.87

Purchase

100

192.31

Purchase

100

191.92

Purchase

131

192.78

Purchase

128

192.13

Purchase

102

192.48

Purchase

302

192.75

Purchase

100

192.94

Purchase

100

192.42

Purchase

7,463

192.88

Sale

1,176

192.88

Sale

100

192.59

Sale

100

192.47

Sale

1

192.35

Sale

10

192.37

Purchase

5

192.57

Sale

66

192.65

Purchase

68

192.80

Sale

10

192.21

Purchase

290

192.71

Sale

101

192.71

Purchase

246

192.70

Sale

302

192.75

Sale

1,296

192.77

Sale

100

192.34

Purchase

10

192.20

Purchase

1,437

192.76

Sale

100

192.74

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

7 February 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 


a d v e r t i s e m e n t